Scholarly Index
Robert S. Kerbel
Sunnybrook Health Science Centre; 52,180 total citations; 460 total publications; best world rank #16
Sunnybrook Health Science Centre
52,180Total citations
460Total publications
111H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cancer Cells and Metastasis | Lifetime | 20 | CA 1 | 99.83 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 27 | CA 4 | 99.87 |
| Angiogenesis and VEGF in Cancer | Lifetime | 16 | CA 1 | 99.81 |
| Cancer Research and Treatments | Lifetime | 20 | CA 1 | 99.79 |
| Cancer Genomics and Diagnostics | Lifetime | 160 | CA 6 | 99.63 |
| Cancer Treatment and Pharmacology | Lifetime | 146 | CA 4 | 99.53 |
| Cancer Mechanisms and Therapy | Lifetime | 62 | CA 2 | 99.10 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 550 | CA 16 | 99.05 |
| HER2/EGFR in Cancer Research | Lifetime | 246 | CA 8 | 98.92 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 423 | CA 9 | 98.62 |
| Melanoma and MAPK Pathways | Lifetime | 186 | CA 4 | 97.86 |
| Glycosylation and Glycoproteins Research | Lifetime | 929 | CA 39 | 97.61 |
| Cancer-related Molecular Pathways | Lifetime | 638 | CA 19 | 97.85 |
| Renal cell carcinoma treatment | Lifetime | 545 | CA 26 | 97.76 |
| Vascular Tumors and Angiosarcomas | Lifetime | 284 | CA 10 | 96.37 |
| Histone Deacetylase Inhibitors Research | Lifetime | 979 | CA 20 | 92.64 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 344 | CA 8 | 73.38 |